- Home
- KZIA vs XWEL Comparison
KZIA vs XWEL Comparison
Compare KZIA & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZIA | XWEL |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 9.0M |
| IPO Year | 2002 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KZIA | XWEL |
|---|---|---|
| Price | $11.32 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.50 | N/A |
| AVG Volume (30 Days) | ★ 198.4K | 93.5K |
| Earning Date | 06-04-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.86 | $0.26 |
| 52 Week High | $17.40 | $2.20 |
Technical Indicators
Market Signals| Indicator | KZIA | XWEL |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 58.96 |
| Support Level | $5.71 | $1.21 |
| Resistance Level | $14.57 | $1.56 |
| Average True Range (ATR) | 1.05 | 0.10 |
| MACD | -0.36 | -0.01 |
| Stochastic Oscillator | 19.41 | 90.16 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About XWEL XWELL Inc.
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.